Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lundbeck CEO Ulf Wiinberg Steps Down After Breaching Code Of Conduct

This article was originally published in The Pink Sheet Daily

Executive Summary

Candidates for the post in the Danish biotech are likely to have a commercial background, as Wiinberg-inspired strategy of geographic expansion and a growing a pipeline of CNS products continues to bear fruit.

You may also be interested in...



Kare Schultz Becomes Lundbeck’s CEO As New Launches Gather Pace

One of the first priorities for Lundbeck’s new chief executive will be supporting new product launches worldwide to boost the Danish company’s geographic and product diversification.

Sanofi Board Forces CEO Chris Viehbacher to Resign Amid Lantus Woes

Sanofi announced that Christopher Viehbacher has resigned as CEO after its board voted unanimously to remove him. The drama comes amid serious worries over the group’s cash cow medicine, Lantus.

Lundbeck Cuts 150 R&D Jobs To Control Costs Ahead Of Key Patent Expiry

Danish pharma increases investment in new product launches as it prepares for loss of patent protection on its lead product, escitalopram.

Topics

Related Companies

UsernamePublicRestriction

Register

PS076669

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel